Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
Wenwen Wang(Fudan University Shanghai Cancer Center), Lei Chen(Shanghai Third People's Hospital), Rui Wu(Second Military Medical University), Dong Gao(Shenzhen Bay Laboratory), Xinyao Qiu(Hainan Tropical Ocean University), Yan Zhao(Wuhan University), Jinxia Bao(Second Military Medical University), Tinggan Yuan(ShanghaiTech University), Siyun Shen(Second Military Medical University), Peng Wang(Chinese Academy of Sciences), Yani Zhang(Yangzhou University), Hongyang Wang(Second Military Medical University), Lili Ma(ShanghaiTech University), Tong Wu(Second Military Medical University), Yanjing Zhu(Shanghai Medical College of Fudan University), Yali Zong(Fudan University), Xiaofang Zhao(Fudan University Shanghai Cancer Center), Shuai Yang(Second Military Medical University)
Cited by 71
Related Papers
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
|Nature Communications|2018|1k
Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing
|Cell Discovery|2020|786
Comprehensive analysis of spatial architecture in primary liver cancer
|Science Advances|2021|359